Skip to Content

Join the 'Venous Thromboembolism' group to help and get support from people like you.

Venous Thromboembolism News

Too Much TV Could Boost Your Odds for a Blood Clot

Posted 22 Feb 2018 by Drugs.com

THURSDAY, Feb. 22, 2018 – Hours spent binge-watching that hot new series might feel great, but it's doing no favors for your blood vessels, new research shows. The study found that people who spend too much time in front of the TV are at increased risk for blood clots in their veins – a condition called venous thromboembolism (VTE). These clots, which often occur in the legs, can dislodge and ...

FDA Approves New 10 mg Dosing for Xarelto (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)

Posted 13 Nov 2017 by Drugs.com

TITUSVILLE, NJ, OCTOBER 30, 2017 – Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) approved the 10 mg once-daily dose of Xarelto (rivaroxaban) for reducing the continued risk for recurrent venous thromboembolism (VTE) after completing at least six months of initial anticoagulation therapy. This approval follows a FDA Priority Review and is based on data f ...

Newer Blood Thinners May Not Bring Higher Bleeding Risk

Posted 18 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 18, 2017 – New anti-clotting drugs – like Xarelto, Pradaxa and Eliquis – aren't linked with a higher risk of bleeding than the older drug warfarin, a new study finds. Many patients who suffer from blood clots in their legs – called venous thromboembolism (VTE) – or have the abnormal heart rhythm called atrial fibrillation take blood thinners to help prevent life-threatening ...

FDA Approves Bevyxxa (betrixaban) for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients

Posted 26 Jun 2017 by Drugs.com

SOUTH SAN FRANCISCO, Calif., June 23, 2017 (GLOBE NEWSWIRE) – Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today announced the U.S. Food and Drug Administration (FDA) has approved Bevyxxa (betrixaban), the first and only anticoagulant for hospital and extended duration prophylaxis (35 to 42 days) of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are ...

FDA Medwatch Alert: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

Posted 13 Jun 2017 by Drugs.com

ISSUE: Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets. ...

Testosterone Therapy May Be Linked to Serious Blood Clots

Posted 1 Dec 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Testosterone treatment can increase a man's risk of potentially fatal blood clots, a new study suggests. Researchers found that men taking the male hormone seem to have a 63 percent increased risk of a blood clot forming in a vein, a condition known as venous thromboembolism (VTE). These clots can cause a heart attack, stroke, organ damage or even death, according to ...

Excess Weight Linked to Blood Clot Risk in Kids

Posted 22 Jan 2016 by Drugs.com

THURSDAY, Jan. 21, 2016 – Obese children and teens may have an increased risk for blood clots in their veins, called venous thromboembolism (VTE), a new study suggests. "This is important because the incidence of pediatric VTE has increased dramatically over the last 20 years, and childhood obesity remains highly prevalent in the United States," lead study author Dr. Elizabeth Halvorson, ...

Time Spent in the OR May Be Linked to Blood Clots, Study Shows

Posted 3 Dec 2014 by Drugs.com

WEDNESDAY, Dec. 3, 2014 – Longer surgery times may increase a patient's risk of dangerous blood clots, a new study suggests. Blood clots are associated with more than 500,000 hospitalizations and 100,000 deaths a year, according to background information in the study. Researchers analyzed data from more than 1.4 million people who had surgery under general anesthesia at 315 U.S. hospitals ...

Common Painkillers Tied to Blood Clot Risk, Study Suggests

Posted 24 Sep 2014 by Drugs.com

WEDNESDAY, Sept. 24, 2014 – People who use painkillers called nonsteroidal anti-inflammatory drugs (NSAIDs) – which include aspirin, naproxen (Aleve) and ibuprofen (Advil, Motrin) – may be at increased risk for potentially deadly blood clots, a new study suggests. But the study only showed an association between use of the painkillers and higher clotting risk; it did not prove ...

Most Treatments for Blood Clots Appear Safe, Effective

Posted 16 Sep 2014 by Drugs.com

TUESDAY, Sept. 16, 2014 – Almost all the various treatment options for blood clots that form in veins are equally safe and effective, new research shows. In exploring the safety and effectiveness of treatments for such blood clots as deep vein thrombosis or pulmonary embolism (blood clot in a lung), Canadian researchers analyzed outcomes associated with eight blood-thinning options, including ...

FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Posted 24 Aug 2014 by Drugs.com

Thursday, August 21, 2014 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for Eliquis for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy. Combined, DVT and PE are known as VTE. It is estimated ...

Urine Test May Help Spot Dangerous Blood Clots

Posted 18 May 2014 by Drugs.com

SUNDAY, May 18, 2014 – Researchers say they've created a simple urine test that detects the presence of dangerous blood clots in the lungs more accurately than the current blood test. The clot typically forms in the leg, where it is called a deep vein thrombosis, but it can break loose and travel to an artery in the lungs. Once lodged there, the clot, now called a pulmonary embolism, can be ...

Study Pinpoints Women at Risk for Blood Clots From Pregnancy

Posted 2 Apr 2013 by Drugs.com

TUESDAY, April 2 – Several factors that increase the risk of blood clots in women during or after pregnancy are outlined in a large new study. Women who were older than 35, who were overweight or obese, or who smoked were at somewhat higher risk of developing blood clots during pregnancy. Medical complications such as pre-existing diabetes, varicose veins and inflammatory bowel disease were also ...

Daily Aspirin May Help Those at Risk for Recurrent Blood Clots

Posted 5 Nov 2012 by Drugs.com

MONDAY, Nov. 5 – About a quarter of people who experience the dangerous blood clots in the legs or lungs known as venous thromboembolisms (VTEs) develop them for no discernable reason, and most will receive a powerful anti-clotting drug such as warfarin in the months after the clot forms. But what about longer-term care, to ward off a recurrent clot, or events such as heart attack or stroke? A ...

Rheumatoid Arthritis May Be Linked to More Blood Clots

Posted 2 Oct 2012 by Drugs.com

TUESDAY, Oct. 2 – New research confirms suspicions that people with rheumatoid arthritis are at somewhat higher risk of developing blood clots in their veins in the decade after diagnosis. The risk appears to be greater during hospitalization, as it is within the general population, the Swedish researchers added. The study, published in the Oct. 3 issue of the Journal of the American Medical ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Pulmonary Embolism, Thromboembolic Disorder

Related Drug Support Groups

Eliquis, apixaban, Fragmin, dalteparin, Bevyxxa, dextran, low molecular weight, betrixaban, Gentran 40, Rheomacrodex, Dextran 40, LMD with 5% Dextrose, Dextran 40 in 5% Dextrose